Jonathan Miller
Stock Analyst at Evercore ISI Group
(n/a)
# 4,347
Out of 4,667 analysts
4
Total ratings
n/a
Success rate
-48.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jonathan Miller
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PROK ProKidney | Initiates: Outperform | n/a | $1.65 | - | 1 | Sep 2, 2022 | |
| TRDA Entrada Therapeutics | Initiates: Outperform | n/a | $17.93 | - | 1 | Nov 24, 2021 | |
| STTK Shattuck Labs | Initiates: Outperform | n/a | $1.11 | - | 1 | Jan 11, 2021 | |
| NBTX Nanobiotix | Initiates: Outperform | n/a | $4.07 | - | 1 | Jan 6, 2021 |
ProKidney
Sep 2, 2022
Initiates: Outperform
Price Target: n/a
Current: $1.65
Upside: -
Entrada Therapeutics
Nov 24, 2021
Initiates: Outperform
Price Target: n/a
Current: $17.93
Upside: -
Shattuck Labs
Jan 11, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.11
Upside: -
Nanobiotix
Jan 6, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.07
Upside: -